The board of Max Financial Services at its meeting held 12 March 2026 has approved raising of fund by way of a qualified institutional placement for an amount not exceeding Rs 2,000 crore.  The proposed utilization of fund raise is primarily to meet the funding requirements of its material subsidiary company, viz., Axis Max Life Insurance, for supporting its business growth and expansion plans and balance for general corporate purposes.

The board also approved increase in authorised share capital of the company from Rs 70 crore to Rs 75 crore.

Saptak Chem & Business will hold a meeting of the Board of Directors of the Company on 17 March 2026.

Kanoria Chemicals & Industries announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 1 April 2026.

Dr Reddys Laboratories has allotted 10,275 equity shares under ESOPs on 12 March 2026.

Dhenu Buildcon Infra will hold a meeting of the Board of Directors of the Company on 14 March 2026.

The Board of Jagsonpal Pharmaceuticals at its meeting held on 12 March 2026 approved a proposal to buyback up to 16,00,000 fully paid-up equity shares of the company at a price of Rs 250 per equity shares (a premium of through Tender Offer method, subject to shareholders approval. This represents 2.4% of the total equity shares of the Company and 7.3% of the non-promoter shareholding of the company. The proposed buyback will be undertaken for an aggregate amount not exceeding Rs 40 crore, representing ~18.4% of the company's total paid-up equity share capital and free reserves based on the latest audited financial statements as of 31 March 2025.

Aarti Industries has entered into a multi-year supply agreement with a top global agrochemical innovator for the supply of a critical agrochemical intermediate used in crop protection formulations. This agreement elevates the current annual engagement to a structured supply contract through 31st March 2030, with a significant increase in volumes. The agreement is expected to generate revenue of approximately USD 150 million over the contract period, providing AIL with enhanced revenue visibility in the medium to long term.

Under the terms of the agreement, AIL will manufacture and supply the intermediate, leveraging its integrated, scalable manufacturing platform, deep process chemistry expertise, and established global regulatory compliance framework. AIL has adequate capacities to meet this requirement and thus this contract supports AIL to attain higher capacity utilisation and volumes without incremental capex. The intermediate will be used by the customer in the manufacturing and formulation of crop-protection products for global agricultural markets.

Sumeet Industries will hold a meeting of the Board of Directors of the Company on 17 March 2026.

Infosys announced the expansion of its Mohali Development Center (DC) with a formal groundbreaking ceremony held at the campus, further strengthening its presence in North India.

As part of this expansion, Infosys will develop a new Software Development Block along with supporting facilities. The expansion is planned to have a built-up area of approximately 350,000 square feet and will seat about 3,000 employees, strengthening Infosys' ability to design, co-create, and deploy AI-led solutions at enterprise scale.

Rekvina Labs will hold a meeting of the Board of Directors of the Company on 16 March 2026.